U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264257) titled 'Choline and Brain Functioning in Postmenopausal Women' on Sept. 10.

Brief Summary: This study will use a randomized placebo-controlled trial to examine a single oral dose of 1650 mg choline influences brain functioning as measured by fMRI.

Study Start Date: June 15, 2022

Study Type: INTERVENTIONAL

Condition: Menopause

Intervention: DIETARY_SUPPLEMENT: Choline

Each subject gets one 1650 mg oral choline dose or placebo on each of two study days.

DIETARY_SUPPLEMENT: Placebo

Each subject gets one 1650 mg oral choline dose or placebo on each of two study days.

Recruitment Status: COMPLETED

Sponsor: University of Vermont

Inform...